Clinical Trial Update: Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating oxytocin for suppressing substance use disorders associated with chronic stress; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Anxiety Disorders
• Post-traumatic Stress Disorder
• Substance Use Disorder

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: Jennifer Mitchell | Conditions: Alcohol Use Disorder, Stress Disorders, Post-Traumatic | Phase 2 | Status: COMPLETED | Results posted: 2020-10-19